MedPath

An interventional study on physicians’ adherence to hypertension guidelines

Not Applicable
Completed
Conditions
Cardiovascular - Hypertension
Hypertension
Public Health - Health service research
Registration Number
ACTRN12614000641695
Lead Sponsor
niversity of Malaya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
555
Inclusion Criteria

All primary care physician working at the Primary Care Clinic at the University Malaya Medical Centre (UMMC) who are treating the cohort of patients with hypertension from earlier phase of this study (patient with hypertension for at least a year and have been followed up at the Primary Care Clinic).

Earlier phase of the study is a retrospective review of records and it is not registered as it is not an intervention trial. We have published a paper from earlier phase of the study :

Liew et al.: Statins use is associated with poorer
glycaemic control in a cohort of hypertensive patients with diabetes and without diabetes. Diabetology & Metabolic Syndrome 2014 6:53. doi:10.1186/1758-5996-6-53

Exclusion Criteria

All primary care physician working at the Primary Care Clinic at the University Malaya Medical Centre (UMMC) who are not treating the cohort of patients with hypertension from earlier phase of the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome is the proportion of patients with controlled blood pressure. Controlled blood pressure is defined as blood pressure less than 140/90mmHg and measured using mercury sphygmomanometer by the doctors. <br>[0 to 3 months post intervention for immediate effect of intervention, 3 to 6 months post intervention for sustainability of intervention]
Secondary Outcome Measures
NameTimeMethod
The rates of documentation of process indicators and outcome indicators from the checklist provided in the medical records: these include the rate of documentation of process indicators (BP, weight measurement, assessment of cardiovascular risk factors, target organ damage and comorbidities, examinations, investigatory tests ordered) and the rate of documentation of outcome indicators (medication use) [0 to 3 months post intervention for immediate effect of intervention, 3 to 6 months post intervention for sustainability of intervention]
© Copyright 2025. All Rights Reserved by MedPath